Private Capital Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
BBA
Private Capital Group's BLUE Position: Q2 2022 in Review
Private Capital Group opened a new position in bluebird bio (BLUE) in Q2 2022: 12 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1671 among its holdings. This is a return to the name: Private Capital Group previously reported a position in BLUE as recently as Q3 2018.
Private Capital Group first reported a position in BLUE in Q3 2018 and has held it in 2 quarters since. 150 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.
- Private Capital Group held 12 shares of bluebird bio worth $1K as of Q2 2022.
- bluebird bio was a new Private Capital Group position in Q2 2022.
- bluebird bio made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1671 holding.
- Private Capital Group first reported a position in bluebird bio in Q3 2018 and has held it in 2 quarters since.
- 150 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.
Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.